Discover what scromiting is, its connection to chronic cannabis use, and why it's causing a surge in emergency room visits across the U.S. Learn about cannabinoid hyperemesis syndrome (CHS) and its ...

While many use marijuana for managing chronic pain or as a way to unwind at the end of the day, according to UW Medicine, ...

A new study challenges what's long been assumed about genetic variants thought to always cause inherited blindness.

Presence of inherited blindness gene does not guarantee vision loss. Only 28% of carriers develop disease, indicating other ...

Discover the top 10 surprising virtual assistant services to outsource in 2025, redefining the way you manage tasks smoothly.

Next year is bringing many changes to the regulatory landscape for skilled nursing. With new payment rules, coding changes ...

The U.S. FDA has approved narsoplimab (Yartemlea) as the first indicated therapy for hematopoietic stem cell ...

Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...

From CMS developments to device coverage, here are 10 payer updates spine surgeons should know headed into 2026: 1. Some fee-for-service spine procedures in traditional Medicare will have prior ...

This is the latest study to suggest that GLP-1s, particularly semaglutide, are tied to a reduced risk for epilepsy in type 2 diabetes.

A new study challenges what's long been assumed about genetic variants thought to always cause inherited blindness.

Hospitals are seeing a striking rise in people with sudden bouts of intense vomiting linked to long-term cannabis use, a condition now formally classified as cannabis hyperemesis syndrome.